scholarly journals Aprotinin's effect on blood product transfusion in off-pump bilateral lung transplantation

2008 ◽  
Vol 8 (1) ◽  
pp. 45-48 ◽  
Author(s):  
K. R. Balsara ◽  
S. T. Morozowich ◽  
S. S. Lin ◽  
R. D. Davis ◽  
B. G. Phillips-Bute ◽  
...  
2007 ◽  
Vol 83 (1) ◽  
pp. 329-330 ◽  
Author(s):  
Hester T. Visser ◽  
Michiel E. Erasmus ◽  
Tjark Ebels

2016 ◽  
Vol 49 (6) ◽  
pp. 461-464
Author(s):  
Young Woo Do ◽  
Hee Suk Jung ◽  
Chang Young Lee ◽  
Jin Gu Lee ◽  
Young-Nam Youn ◽  
...  

Author(s):  
Philipp Foessleitner ◽  
Konrad Hoetzenecker ◽  
Alberto Benazzo ◽  
Katrin Klebermass‐Schrehof ◽  
Anke Scharrer ◽  
...  

2020 ◽  
Vol 3 ◽  
pp. 400-402
Author(s):  
Ben Dunne ◽  
Philippe Lemaître ◽  
Marc de Perrot ◽  
Cecilia Chaparro ◽  
Shaf Keshavjee

2021 ◽  
Vol 30 (3) ◽  
pp. 178-183
Author(s):  
Kate McEwen ◽  
Lyndell Brodie

Lung transplantation is a well-established treatment for a variety of end-stage pulmonary diseases. However, the journey of a lung transplant recipient is complex and multifaceted. Silicosis is a rare indication for lung transplantation, but no other treatment is yet available for this disease in its end stages. This Australian case study presents a 52-year-old man with silicosis who received bilateral lung transplantation. The patient was frequently noncompliant with noninvasive ventilation therapy and experienced the complication of type 2 respiratory failure. Patient education and support provided, particularly around medication management following transplantation surgery, are discussed here. The patient's social situation and its implications for both him and his family are also considered.


Sign in / Sign up

Export Citation Format

Share Document